The probability of overall survival after 1, 5, and 10 years was predicted by a nomogram model, which found that worse Surveillance, Epidemiology, and End Results (SEER) stage was associated with ...

Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. A phase II study of an oncolytic herpes simplex virus 2 and an anti-PD-1 antibody in patients with ...

SAN ANTONIO — July is Sarcoma Awareness Month, a time to bring attention to many deadly types of cancer. One of those is called synovial sarcoma, which typically presents itself as a painful lump ...

KUTV — July is Sarcoma Awareness Month, a time to raise understanding about rare cancers like synovial sarcoma—a life-threatening soft tissue cancer that often appears as a painful lump near the knee, ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found. The group irradiated ...

Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.

The FDA granted accelerated approval to afamitresgene autoleucel (afami-cel, Tecelra) for treating advanced synovial sarcoma, the first engineered cell therapy indicated for a solid tumor. An ...

Plasma is irradiated from a non-thermal atmospheric-pressure plasma device onto a mammalian cell culture medium to produce PAM. Plasma-activated medium (PAM) shows tumor-fighting effects against the ...

Synovial sarcoma is a rare, aggressive malignancy with deceptive benign presentation, complicating diagnosis and delaying treatment. Molecular confirmation of SS18-SSX fusion genes is crucial for ...

In the sport of sumo, a bout most commonly ends when one competitor is pushed or thrown outside of a ring of straw bales partially buried in clay. New research shows that using a drug as a blocker to ...

Ramucirumab in pediatric and young adult patients (Pts) with relapsed/refractory (R/R) desmoplastic small round cell tumor (DSRCT) or synovial sarcoma (SS): Results from the CAMPFIRE study. This is an ...